Can erythropoietin be used to prevent brain damage in cerebral malaria?
Erythropoietin (Epo) modulates the survival of developing erythroid cells and the production of new erythrocytes in the bone marrow and is a key molecule in the adaptation to hypoxia and anaemia. Epo receptors have been found to be widely expressed on non-haematopoietic cells, and Epo has been shown...
Auteurs principaux: | Casals-Pascual, C, Idro, R, Picot, S, Roberts, D, Newton, C |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2009
|
Documents similaires
-
Erythropoietin and neuro-protection in African children with cerebral malaria
par: Idro, R, et autres
Publié: (2008) -
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria.
par: Casals-Pascual, C, et autres
Publié: (2008) -
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.
par: Idro, R, et autres
Publié: (2010) -
Pathogenesis, clinical features, and neurological outcome of cerebral malaria.
par: Idro, R, et autres
Publié: (2005) -
A better biomarker for cerebral malaria: in the eye of the beheld?*.
par: Ackerman, H, et autres
Publié: (2012)